Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Total Liabilities (2016 - 2025)

Icu Medical's Total Liabilities history spans 17 years, with the latest figure at $1.9 billion for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 13.94% year-over-year to $1.9 billion, compared with a TTM value of $1.9 billion through Dec 2025, down 13.94%, and an annual FY2025 reading of $1.9 billion, down 13.94% over the prior year.
  • Total Liabilities for Q4 2025 was $1.9 billion at Icu Medical, down from $2.0 billion in the prior quarter.
  • The five-year high for Total Liabilities was $2.6 billion in Q1 2022, with the low at $244.5 million in Q1 2021.
  • Average Total Liabilities over 5 years is $1.9 billion, with a median of $2.2 billion recorded in 2024.
  • Year-over-year, Total Liabilities crashed 45.09% in 2021 and then surged 950.4% in 2022.
  • Tracing ICUI's Total Liabilities over 5 years: stood at $264.7 million in 2021, then surged by 816.38% to $2.4 billion in 2022, then decreased by 7.04% to $2.3 billion in 2023, then fell by 0.72% to $2.2 billion in 2024, then decreased by 13.94% to $1.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Total Liabilities are $1.9 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.0 billion (Q2 2025).